SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-19-005639
Filing Date
2019-03-01
Accepted
2019-03-01 06:05:46
Documents
87
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nktr-10k_20181231.htm 10-K 3483374
2 EX-10.9 nktr-ex109_7.htm EX-10.9 292159
3 EX-21.1 nktr-ex211_10.htm EX-21.1 6820
4 EX-23.1 nktr-ex231_6.htm EX-23.1 3750
5 EX-31.1 nktr-ex311_8.htm EX-31.1 8187
6 EX-31.2 nktr-ex312_11.htm EX-31.2 8171
7 EX-32.1 nktr-ex321_12.htm EX-32.1 7662
8 GRAPHIC gotijzibnorn000001.jpg GRAPHIC 45252
  Complete submission text file 0001564590-19-005639.txt   12340807

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT nktr-20181231.xml EX-101.INS 2591089
10 XBRL TAXONOMY EXTENSION SCHEMA nktr-20181231.xsd EX-101.SCH 92376
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktr-20181231_cal.xml EX-101.CAL 73406
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20181231_def.xml EX-101.DEF 301551
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20181231_lab.xml EX-101.LAB 634931
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20181231_pre.xml EX-101.PRE 487431
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24006 | Film No.: 19646586
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences